As a risk factor for future serious health conditions, the early prevention, detection and management of type 2 diabetes are ...

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and ...

Biogen plans to start a Phase III trial for felzartamab as a treatment for antibody-mediated rejection, and two other ...

Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...

At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing ...

Arda Therapeutics has secured $43m in Series A financing led by Andreessen Horowitz to develop targeted cell depletion ...

Patient recruitment is a critical yet challenging phase in clinical trials. EMIS has been lauded for its significant ...

Boehringer Ingelheim and Circle Pharma have signed a partnership and licence agreement focused on developing a new cancer ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.

Emergent said it is separately working on increasing the availability of its overdose reverser on site for businesses.